Classifications

• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
  • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
  • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
  • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P9/00—Drugs for disorders of the cardiovascular system
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P9/00—Drugs for disorders of the cardiovascular system
  • A61P9/08—Vasodilators for multiple indications
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P9/00—Drugs for disorders of the cardiovascular system
  • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
  • C07C381/00—Compounds containing carbon and sulfur and having functional groups not covered by groups C07C301/00 - C07C337/00
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
  • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
  • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
  • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
  • C07D211/40—Oxygen atoms
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
  • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
  • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
  • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
  • C07D211/54—Sulfur atoms
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
  • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
  • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
  • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
  • C07D211/56—Nitrogen atoms
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07K—PEPTIDES
  • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
  • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
  • C07K5/0215—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing natural amino acids, forming a peptide bond via their side chain functional group, e.g. epsilon-Lys, gamma-Glu
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K38/00—Medicinal preparations containing peptides

Landscapes

• Chemical & Material Sciences (AREA)
• Organic Chemistry (AREA)
• Health & Medical Sciences (AREA)
• Medicinal Chemistry (AREA)
• General Health & Medical Sciences (AREA)
• Life Sciences & Earth Sciences (AREA)
• Engineering & Computer Science (AREA)
• Bioinformatics & Cheminformatics (AREA)
• Veterinary Medicine (AREA)
• Public Health (AREA)
• General Chemical & Material Sciences (AREA)
• Pharmacology & Pharmacy (AREA)
• Chemical Kinetics & Catalysis (AREA)
• Animal Behavior & Ethology (AREA)
• Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
• Biochemistry (AREA)
• Biophysics (AREA)
• Proteomics, Peptides & Aminoacids (AREA)
• Molecular Biology (AREA)
• Genetics & Genomics (AREA)
• Cardiology (AREA)
• Heart & Thoracic Surgery (AREA)
• Vascular Medicine (AREA)
• Urology & Nephrology (AREA)
• Hematology (AREA)
• Diabetes (AREA)
• Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
• Peptides Or Proteins (AREA)
• Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
• Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
• Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
• Hydrogenated Pyridines (AREA)
• Pyrane Compounds (AREA)
• Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)

Applications Claiming Priority (3)

Publications (1)

Family

ID=8307080

Family Applications (1)

Country Status (37)

Families Citing this family (4)

Family Cites Families (16)

• 1999
  • 1999-01-27 ES ES009900159A patent/ES2147162B1/es not_active Expired - Fee Related
• 2000
  • 2000-01-19 ID IDW00200101662A patent/ID29777A/id unknown
  • 2000-01-19 HU HU0105203A patent/HUP0105203A3/hu unknown
  • 2000-01-19 AP APAP/P/2001/002247A patent/AP1439A/en active
  • 2000-01-19 DK DK00900518T patent/DK1157987T3/da active
  • 2000-01-19 CZ CZ20012678A patent/CZ298871B6/cs not_active IP Right Cessation
  • 2000-01-19 MX MXPA01007570A patent/MXPA01007570A/es not_active IP Right Cessation
  • 2000-01-19 RS YUP-536/01A patent/RS50072B/sr unknown
  • 2000-01-19 EP EP00900518A patent/EP1157987B1/en not_active Expired - Lifetime
  • 2000-01-19 AU AU30460/00A patent/AU764725B2/en not_active Ceased
  • 2000-01-19 GE GEAP20006075A patent/GEP20043220B/en unknown
  • 2000-01-19 WO PCT/ES2000/000019 patent/WO2000044714A1/es active IP Right Grant
  • 2000-01-19 DE DE60005154T patent/DE60005154T2/de not_active Expired - Lifetime
  • 2000-01-19 ES ES00900518T patent/ES2206178T3/es not_active Expired - Lifetime
  • 2000-01-19 JP JP2000595971A patent/JP3795330B2/ja not_active Expired - Fee Related
  • 2000-01-19 TR TR2001/02003T patent/TR200102003T2/xx unknown
  • 2000-01-19 KR KR1020017009522A patent/KR100671878B1/ko not_active IP Right Cessation
  • 2000-01-19 OA OA1200100195A patent/OA11823A/en unknown
  • 2000-01-19 GB GB0120581A patent/GB2363604B/en not_active Expired - Fee Related
  • 2000-01-19 DE DE10083902T patent/DE10083902T1/de not_active Ceased
  • 2000-01-19 BR BRPI0007395-4A patent/BR0007395B1/pt not_active IP Right Cessation
  • 2000-01-19 PL PL349006A patent/PL202372B1/pl not_active IP Right Cessation
  • 2000-01-19 IL IL14438100A patent/IL144381A/xx not_active IP Right Cessation
  • 2000-01-19 EA EA200100823A patent/EA003577B1/ru not_active IP Right Cessation
  • 2000-01-19 EE EEP200100389A patent/EE04524B1/xx not_active IP Right Cessation
  • 2000-01-19 CN CNB008030847A patent/CN1166631C/zh not_active Expired - Fee Related
  • 2000-01-19 NZ NZ513162A patent/NZ513162A/xx not_active IP Right Cessation
  • 2000-01-19 SI SI200030236T patent/SI1157987T1/xx unknown
  • 2000-01-19 CA CA002359027A patent/CA2359027C/en not_active Expired - Fee Related
  • 2000-01-19 AT AT00900518T patent/ATE249428T1/de not_active IP Right Cessation
  • 2000-01-19 PT PT00900518T patent/PT1157987E/pt unknown
• 2001
  • 2001-07-06 NO NO20013385A patent/NO326806B1/no not_active IP Right Cessation
  • 2001-07-23 IS IS6020A patent/IS2153B/is unknown
  • 2001-07-24 US US09/912,164 patent/US6800612B2/en not_active Expired - Fee Related
  • 2001-07-26 ZA ZA200106182A patent/ZA200106182B/en unknown
  • 2001-07-26 HR HR20010562A patent/HRP20010562B1/xx not_active IP Right Cessation
  • 2001-07-30 CU CU20010181A patent/CU23098A3/es not_active IP Right Cessation
  • 2001-08-16 BG BG105824A patent/BG64983B1/bg unknown
• 2002
  • 2002-05-28 HK HK02103982.2A patent/HK1043586A1/zh unknown

Also Published As

Similar Documents